Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

CNS 8Gynecologic 7Breast 6Genitourinary 5Gastrointestinal 5Sarcoma 3Other solid neoplasm 3Other hematologic neoplasm 3Lymphoid 3Head & Neck 3Tumor-Agnostic 1Plasma cell 1Other 1Endocrine 1Dermatologic 1

Conditions

Melanoma 1

Interventions

pembrolizumab 326Nivolumab 289Ipilimumab 260Cyclophosphamide 193aldesleukin 145Interleukin-2 109fludarabine phosphate 106Temozolomide 83Dacarbazine 81fludarabine 80Radiotherapy 74trametinib 73Vemurafenib 69dabrafenib 66Biopsy 65sargramostim 50Bevacizumab 50Radiosurgery 49Paclitaxel 49Peripheral Blood Stem Cell Transplantation 48Carboplatin 48Magnetic Resonance Spectroscopy 47Imiquimod 47Aminolevulinic Acid 47binimetinib 45Cisplatin 45CTLA-4 Antigen 43cemiplimab 42atezolizumab 41Specimen Handling 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Restraint, Physical × Dermatologic × Clear all
NCT05027009 2022-06-09

Effects of Simulated Solar Radiation on Human Skin in Preventing Skin Cancer

OHSU Knight Cancer Institute

Phase NA Completed
6 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡